Cite
Targeted delivery of CEBPA-saRNA for the treatment of pancreatic ductal adenocarcinoma by transferrin receptor aptamer decorated tetrahedral framework nucleic acid
MLA
Li Wang, et al. “Targeted Delivery of CEBPA-SaRNA for the Treatment of Pancreatic Ductal Adenocarcinoma by Transferrin Receptor Aptamer Decorated Tetrahedral Framework Nucleic Acid.” Journal of Nanobiotechnology, vol. 22, no. 1, July 2024, pp. 1–15. EBSCOhost, https://doi.org/10.1186/s12951-024-02665-4.
APA
Li Wang, Qunyan Yao, Xuerui Guo, Bingmei Wang, Jingyi Si, Xingye Wang, Shisong Jing, Ming Yan, Yan Shi, Guangqi Song, Xizhong Shen, Jiyu Guan, Yicheng Zhao, & Changfeng Zhu. (2024). Targeted delivery of CEBPA-saRNA for the treatment of pancreatic ductal adenocarcinoma by transferrin receptor aptamer decorated tetrahedral framework nucleic acid. Journal of Nanobiotechnology, 22(1), 1–15. https://doi.org/10.1186/s12951-024-02665-4
Chicago
Li Wang, Qunyan Yao, Xuerui Guo, Bingmei Wang, Jingyi Si, Xingye Wang, Shisong Jing, et al. 2024. “Targeted Delivery of CEBPA-SaRNA for the Treatment of Pancreatic Ductal Adenocarcinoma by Transferrin Receptor Aptamer Decorated Tetrahedral Framework Nucleic Acid.” Journal of Nanobiotechnology 22 (1): 1–15. doi:10.1186/s12951-024-02665-4.